BIOTRONIK Revenue and Competitors
Estimated Revenue & Valuation
- BIOTRONIK's estimated annual revenue is currently $1.3B per year.
- BIOTRONIK's estimated revenue per employee is $251,000
Employee Data
- BIOTRONIK has 5197 Employees.
- BIOTRONIK grew their employee count by 2% last year.
BIOTRONIK's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Area VP | Reveal Email/Phone |
3 | Global VP Sales - Neuromodulation | Reveal Email/Phone |
4 | Assistentin VP Corporate Tax & Legal | Reveal Email/Phone |
5 | VP | Reveal Email/Phone |
6 | CPO & VP Corporate Procurement | Reveal Email/Phone |
7 | Area VP | Reveal Email/Phone |
8 | Head Corporate Environment, Health and Safety | Reveal Email/Phone |
9 | Head Corporate Treasury | Reveal Email/Phone |
10 | General Counsel | Reveal Email/Phone |
BIOTRONIK Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $31800M | 109578 | 4% | $367M | $146B |
#2 | $68.5M | 273 | N/A | N/A | N/A |
What Is BIOTRONIK?
BIOTRONIK is a leading medical device company that has been developing trusted and innovative cardiovascular and endovascular solutions for more than 50 years. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.
keywords:N/A
N/A
Total Funding
5197
Number of Employees
$1.3B
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BIOTRONIK News
Aerotel Medical Systems (1988) Ltd., Biotronik SE & Co. KG themobility.club...
Biotronik; Boston Scientific; Cook Medical; W.L. Gore & Associates; C.R. Bard; Terumo; Abbott Laboratories; B. Braun Melsungen; Medtronic. Intravascular...
Biotronik announced today that the FDA approved its Renamic Neo programmer for implanted cardiac rhythm management devices.
BERLIN, July 28, 2021 /PRNewswire/ -- In association with Heart Rhythm 2021, BIOTRONIK today announced that the latest implantable cardiac monitor (ICM), BIOMONITOR IIIm, has been recognized by internationally-renowned research analysts Frost & Sullivan as high-performing across a range of inn ...
Biotronik said yesterday that its Orsiro stent tops the Xience stents made by Abbott (NYSE:ABT) when it comes to target lesion failure, according to data from a clinical trial. The randomized, controlled BioSTEMI trial was the first direct comparison between the two drug-eluting stents in patie ...